Amanda Burkardt

Amanda Burkardt

Company: Phiogen Pharma

Job title: CEO

Seminars:

Improving Patient Selection, Recruitment & Clinical Trial Design to Advance Bacteriophage Therapies Across a Wide Range of Indications 9:00 am

As the bacteriophage field continues pushing forward, the need for pivotal clinical trials grows stronger. The design, dosing, administration, and patient recruitment are all important factors into making the trial as effective as possible. In this workshop, we will cover the questions: What diagnostic assays can be employed to identify and recruit relevant patients on…Read more

day: Pre-Conference Workshop Day

Spearheading the Investment Opportunities for Bacteriophage Therapies to Become the Standard of Care in Antibiotic Resistant Infections 1:00 pm

Investment and funding is vital to secure for bacteriophage companies to develop effective therapies and proceed to the clinic for randomized, pivotal clinical trials. Demonstrating the untapped potential of bacteriophages to treat antibiotic-resistant infections and beyond to investors is a necessary step on the path to replacing antibiotics as the standard of care. Join us…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.